Author details

Full Name

Abhishek Niroula

Affiliation

ORCID

Career Start Year

2015

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
37952204	Clonal haematopoiesis of indeterminate potential predicts incident cardiac arrhythmias.	Eur Heart J	2024
37483562	Prediction of risk for myeloid malignancy in clonal hematopoiesis.	NEJM Evid	2023
37666355	Functional and molecular profiling of hematopoietic stem cells during regeneration.		2023
37909388	Somatic TET2 Mutations are Associated with Giant Cell Arteritis.		2023
37732181	Long-term longitudinal analysis of 4,187 participants reveals new insights into determinants of incident clonal hematopoiesis.	medRxiv	2023
37863054	SRCAP mutations drive clonal hematopoiesis through epigenetic and DNA repair dysregulation.	Cell Stem Cell	2023
37345823	Birth Weight Is Associated With Clonal Hematopoiesis of Indeterminate Potential and Cardiovascular Outcomes in Adulthood.		2023
36652671	A practical approach to curate clonal hematopoiesis of indeterminate potential in human genetic data sets.	Blood	2023
36949957	<i>TP53-</i>mediated clonal hematopoiesis confers increased risk for incident atherosclerotic disease.	Nat Cardiovasc Res	2023
37197843	Clonal Hematopoiesis of Indeterminate Potential Predicts Adverse Outcomes in Patients With Atherosclerotic Cardiovascular Disease.		2023
37071471	Obesity-induced inflammation exacerbates clonal hematopoiesis.	J Clin Invest	2023
36480766	Clonal Hematopoiesis and Risk of Incident Lung Cancer.	J Clin Oncol	2023
36997024	HLA Class I Genotype Is Associated with Relapse Risk after Allogeneic Stem Cell Transplantation for NPM1-Mutated Acute Myeloid Leukemia.	Transplant Cell Ther	2023
37498674	Genetic modification of inflammation- and clonal hematopoiesis-associated cardiovascular risk.	J Clin Invest	2023
35007327	Genome-wide association study on 13â¿¿167 individuals identifies regulators of blood CD34+cell levels.	Blood	2022
35714308	TET2-mutant clonal hematopoiesis and risk of gout.	Blood	2022
35387875	Clonal Hematopoiesis and CKD Progression.	Journal of the American Society of Nephrology : JASN	2022
35508625	Genetics of smoking and risk of clonal hematopoiesis.	Sci Rep	2022
35385311	Mendelian randomization supports bidirectional causality between telomere length and clonal hematopoiesis of indeterminate potential.	Sci Adv	2022
36513657	Author Correction: Functional dissection of inherited non-coding variation influencing multiple myeloma risk.	Nat Commun	2022
34743536	Clonal Hematopoiesis Is Associated With Higher Risk of Stroke.	Stroke	2022
34855941	Association of clonal hematopoiesis with chronic obstructive pulmonary disease.	Blood	2022
35013207	Functional dissection of inherited non-coding variation influencing multiple myeloma risk.	Nat Commun	2022
34698806	Dnmt3a-mutated clonal hematopoiesis promotes osteoporosis.	J Exp Med	2021
34127679	Prognostic implications of troponin T variations in inherited cardiomyopathies using systems biology.	NPJ Genom Med	2021
33627649	Accelerating target deconvolution for therapeutic antibody candidates using highly parallelized genome editing.	Nature Communications	2021
34106216	Association of Diet Quality With Prevalence of Clonal Hematopoiesis and Adverse Cardiovascular Events.	JAMA Cardiology	2021
34210413	Supplemental Association of Clonal Hematopoiesis With Incident HeartÂ Failure.	J Am Coll Cardiol	2021
33875642	Germline variants at SOHLH2 influence multiple myeloma risk.	Blood Cancer J	2021
33161765	Premature Menopause, Clonal Hematopoiesis, and Coronary Artery Disease in Postmenopausal Women.	Circulation	2021
34568833	<i>ZBTB33</i> is mutated in clonal hematopoiesis and myelodysplastic syndromes and impacts RNA splicing.	Blood Cancer Discov	2021
34782614	Author Correction: Germline variants at SOHLH2 influence multiple myeloma risk.	Blood Cancer J	2021
34663986	Distinction of lymphoid and myeloid clonal hematopoiesis.	Nat Med	2021
32555370	S100A6 is a critical regulator of hematopoietic stem cells.	Leukemia	2020
32150605	Identification of germline variants in adults with hemophagocytic lymphohistiocytosis.	Blood advances	2020
32665696	Correction: S100A6 is a critical regulator of hematopoietic stem cells.	Leukemia	2020
31359027	MPRAscore: robust and non-parametric analysis of massively parallel reporter assays.		2019
31684883	ProTstab - predictor for cellular protein stability.	BMC Genomics	2019
30742610	How good are pathogenicity predictors in detecting benign variants?	PLoS Comput Biol	2019
29597263	PON-tstab: Protein Variant Stability Predictor. Importance of Training Data Quality.	Int J Mol Sci	2018
29695719	The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression.	Nature Communications	2018
28224672	PON-P and PON-P2 predictor performance in CAGI challenges: Lessons learned.	Hum Mutat	2017
28634997	Working toward precision medicine: Predicting phenotypes from exomes in the Critical Assessment of Genome Interpretation (CAGI) challenges.	Hum Mutat	2017
28440912	Performance of in silico tools for the evaluation of p16INK4a (CDKN2A) variants in CAGI.	Hum Mutat	2017
29296704	Direct evidence for a polygenic etiology in familial multiple myeloma.	Blood Adv	2017
28070986	Predicting Severity of Disease-Causing Variants.	Hum Mutat	2017
26987456	Variation Interpretation Predictors: Principles, Types, Performance, and Choice.	Hum Mutat	2016
27153720	PON-Sol: prediction of effects of amino acid substitutions on protein solubility.	Bioinformatics	2016
26843426	PON-mt-tRNA: a multifactorial probability-based method for classification of mitochondrial tRNA variations.	Nucleic Acids Res	2016
26282678	Harmful somatic amino acid substitutions affect key pathways in cancers.	BMC Med Genomics	2015